Conducting Real-World Evidence (RWE) research in oncology requires access to diverse data sources, such as patient registries, electronic health records (EHR), claims data, and cancer-specific databases. These data sources often vary in completeness and quality limiting their suitability. Additionally, the rapid advancement of cancer therapies, including immunotherapies, targeted therapies, and combination treatments, complicates the ability… Continue reading Bridging the Gap: Key Data Elements in Oncology RCTs vs. RWD